VELMANASE ALFA-TYCV

VELMANASE ALFA-TYCV was reported 56 times

VELMANASE ALFA-TYCV is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TESTICULAR GERM CELL TUMOUR 1 0.0323
1 CONGENITAL MUSCULOSKELETAL DISORDER OF SKULL 1 0.0139
2 ADENOIDITIS 1 0.0079
3 CYSTATIN C INCREASED 1 0.0078
4 GASTROINTESTINAL POLYP 1 0.0030
5 ENDOMETRIAL ABLATION 1 0.0028
6 GASTRIC FISTULA 1 0.0022
7 VASCULAR ACCESS COMPLICATION 1 0.0012
8 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
9 ANTIBODY TEST POSITIVE 1 0.0006
10 VEIN RUPTURE 1 0.0006
11 SCHIZOAFFECTIVE DISORDER 1 0.0006
12 NASAL OBSTRUCTION 1 0.0005
13 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
14 HYPERCAPNIA 1 0.0003
15 ABDOMINAL ADHESIONS 1 0.0003
16 EAR PRURITUS 1 0.0003
17 BONE DENSITY ABNORMAL 1 0.0003
18 METASTATIC NEOPLASM 1 0.0002
19 INFLAMMATORY MARKER INCREASED 1 0.0002
20 PRODUCT COMPLAINT 5 0.0002
21 BLOOD LACTIC ACID INCREASED 1 0.0002
22 CHOLECYSTITIS ACUTE 1 0.0002
23 ENERGY INCREASED 1 0.0002
24 SYMPTOM RECURRENCE 1 0.0002
25 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
26 ECCHYMOSIS 1 0.0001
27 PAPULE 1 0.0001
28 PANIC REACTION 1 0.0001
29 DECUBITUS ULCER 1 0.0001
30 IMMUNOSUPPRESSION 1 0.0001
31 GASTROINTESTINAL INFECTION 1 0.0001
32 OSTEOMYELITIS 2 0.0001
33 PNEUMONIA BACTERIAL 1 0.0001
34 AFFECT LABILITY 1 0.0001
35 TOOTH ABSCESS 1 0.0001
36 HYPERTENSIVE CRISIS 1 0.0001
37 BLOOD IRON DECREASED 1 0.0001
38 ATAXIA 1 0.0001
39 BEDRIDDEN 1 0.0001
40 DEVICE OCCLUSION 1 0.0001
41 BRONCHOSPASM 1 0.0001
42 GASTROENTERITIS 1 0.0001
43 BONE LOSS 1 0.0001
44 GASTROENTERITIS VIRAL 1 0.0001
45 TOOTHACHE 1 0.0001
46 C-REACTIVE PROTEIN INCREASED 2 0.0001
47 ARTHROPATHY 3 0.0001
48 BACTERIAL INFECTION 1 0.0001
49 FOOT FRACTURE 1 0.0001
50 PRESCRIBED OVERDOSE 1 0.0001
51 INFUSION RELATED REACTION 3 0.0000
52 RESPIRATORY TRACT INFECTION 1 0.0000
53 GASTRITIS 1 0.0000
54 PALLOR 1 0.0000
55 PNEUMONITIS 1 0.0000
56 PSYCHOTIC DISORDER 1 0.0000
57 FEMUR FRACTURE 1 0.0000
58 BLOOD CREATININE INCREASED 2 0.0000
59 CHOLELITHIASIS 1 0.0000
60 STAPHYLOCOCCAL INFECTION 1 0.0000
61 HAEMOGLOBIN DECREASED 3 0.0000
62 SEPTIC SHOCK 1 0.0000
63 CONTUSION 2 0.0000
64 LUNG DISORDER 1 0.0000
65 PRODUCT DOSE OMISSION ISSUE 6 0.0000
66 HEART RATE INCREASED 2 0.0000
67 INFLAMMATION 1 0.0000
68 BRADYCARDIA 1 0.0000
69 DISTURBANCE IN ATTENTION 1 0.0000
70 HAEMATOCHEZIA 1 0.0000
71 ANAPHYLACTIC REACTION 1 0.0000
72 URTICARIA 3 0.0000
73 OXYGEN SATURATION DECREASED 1 0.0000
74 WHEEZING 1 0.0000
75 ILL-DEFINED DISORDER 1 0.0000
76 FEELING HOT 1 0.0000
77 RHINORRHOEA 1 0.0000
78 HEPATIC ENZYME INCREASED 1 0.0000
79 PYREXIA 5 0.0000
80 BRONCHITIS 1 0.0000
81 HALLUCINATION 1 0.0000
82 ABDOMINAL PAIN 3 0.0000
83 TACHYCARDIA 1 0.0000
84 GASTROINTESTINAL DISORDER 1 0.0000
85 OROPHARYNGEAL PAIN 1 0.0000
86 DYSPHAGIA 1 0.0000
87 SYNCOPE 1 0.0000
88 ERYTHEMA 2 0.0000
89 INFLUENZA 1 0.0000
90 SEPSIS 1 0.0000
91 WEIGHT INCREASED 2 0.0000
92 MUSCULAR WEAKNESS 1 0.0000
93 INCORRECT DOSE ADMINISTERED 2 0.0000
94 CHILLS 1 0.0000
95 VOMITING 4 0.0000
96 DISEASE PROGRESSION 1 0.0000
97 JOINT SWELLING 1 0.0000
98 OEDEMA PERIPHERAL 1 0.0000
99 VISUAL IMPAIRMENT 1 0.0000
100 LOSS OF CONSCIOUSNESS 1 0.0000
101 INFECTION 1 0.0000
102 TREMOR 1 0.0000
103 HYPERSENSITIVITY 1 0.0000
104 HYPOTENSION 1 0.0000
105 SOMNOLENCE 1 0.0000
106 OFF LABEL USE 4 0.0000
107 MALAISE 2 0.0000
108 FEELING ABNORMAL 1 0.0000
109 COUGH 1 0.0000
110 DYSPNOEA 2 0.0000
111 ANXIETY 1 0.0000
112 DIARRHOEA 2 0.0000
113 PNEUMONIA 1 0.0000
114 FALL 1 0.0000
115 ASTHENIA 1 0.0000
116 PRURITUS 1 0.0000
117 FATIGUE 2 0.0000
118 ARTHRALGIA 1 0.0000
119 PAIN 1 0.0000
120 HEADACHE 1 0.0000
121 DEATH 1 0.0000